Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Sun Pharma Advanced Research Co Ltd

SPARC.NS ✓ COMPLIANT ☆ Track — members

NSE India · Healthcare · Pharmaceuticals ·

India Small Cap Analyst: N/A

Last Close

$2.07

▼ -3.08%

Market Cap $673.19M · Vol 945.38K

Key Metrics

P/E Ratio

4.05

FWD: N/A

Market Cap

$673.19M

Small Cap

Div Yield

N/A

EPS Growth

N/A

YoY

RSI (14)

34.63

Momentum

Beta

1.60

vs Market

52W High

$3.03

31.42% below

52W Low

$1.13

79.00% above

Volume

945.38K

Avg 2.06M

P/B

2.78

Price-to-book

ROE

N/A

Return on equity

Free Float

24.88%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, Sun Pharma Advanced Research Co Ltd (SPARC.NS) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does SPARC.NS pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

-7.14%

-20.11%

+16.40%

+49.87%

YTD

+47.25%

+41.17%

-24.46%

-29.34%

Financials & Valuation

TTM · Annual

Total Revenue	$4.19M
Net Income	$166.19M
Revenue Growth (YoY)	+314.11%
Gross Margin	-73.34%
Operating Margin	-615.84%
Net Profit Margin	3,967.49%
ROE	N/A
ROA · ROIC	123.92% · 162.52%

P/E Ratio	4.05
Forward P/E (FY1)	N/A
PEG Ratio	0.00
P/S	95.24
P/B	2.78
P/FCF	N/A
EPS Growth	N/A
Outstanding Shares	324.52M

Technical Indicators

50-Day SMA	$2.38
200-Day SMA	$1.71
RSI (14)	34.63
Beta	1.60
52-Week High	$3.03
52-Week Low	$1.13

Volume Today	945.38K
Avg Daily Volume (30D)	2.06M
Relative Volume	0.46x
Volatility (10D)	35.90
Volatility (30D)	48.09
Free Float	24.88%

Analyst Consensus

N/A

Current Price $2.07

Mean Target N/A

52W Low$1.13 52W High$3.03

Current

Target

$1.13 $3.03

Current Analyst target

· 0 analysts

Identifiers

ExchangeNSE India

FIGIBBG001ST2DB0

ISININE232I01014

CountryIndia

Sub-IndustryPharmaceuticals (NEC)

Earnings DateN/A

TypeStocks

Instrument TypeFULLPAID Fully Paid Ordinary

Similar Halal Stocks

LLY Eli Lilly and Co -2.39% JNJ Johnson & Johnson -0.66% ABBV Abbvie Inc -0.54% NVS Novartis AG -0.55% NOVN.S Novartis AG -1.05%

Company Profile

Sun Pharma Advanced Research Company Limited is an India-based clinical-stage biopharmaceutical company that focuses on developing therapeutics to improve standards of care for patients worldwide. The Company’s therapeutic focus is in the area of oncology, neurology and immunology. Its lead oncology programs include vodobatinib (SCO-088), a BCR-ABL targeting tyrosine kinase inhibitor for refractory chronic myelogenous leukemia, and an anti-MUC-1 antibody-drug conjugate (ADC) with the potential to treat multiple cancers. The Company’s other programs include Sezaby for the treatment of neonatal seizures, Vodobatinib for the treatment of neurodegenerative disorders (SCC-138), Vibozilimod for the treatment of autoimmune disorders (SCD-044), SCD-153 for the treatment of alopecia areata, SBO-154 for multiple cancer indications and SCO-155 for treatment of cancer. SBO-154 is an anti MUC1 ADC being developed for multiple tumor types expressing MUC1.